Loading…

Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats

Neuromedin B (NMB) has potentially great impacts on the development of cardiovascular diseases by promoting hypertensive and sympatho-excitation effects. However, studies regarding the NMB function in paraventricular nucleus (PVN) are lacking. With selective neuromedin B receptor (NMBR) antagonist,...

Full description

Saved in:
Bibliographic Details
Published in:Brain research bulletin 2025-01, Vol.220, p.111180, Article 111180
Main Authors: Liu, Kai-Li, Sun, Tian-Ze, Yang, Yu, Gao, Qian-Xi, Tu, Li-Mei, Yu, Jia-Yue, Tian, Qiao-Zhen, Fu, Li-Yan, Tang, Shu-Huan, Gao, Hong-Li, Qi, Jie, Kang, Yu-Ming, Yu, Xiao-Jing
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2347-414ae930facaccc19b1edbfc2cfec046c8140cd6eb42ffd8f2f9a0fe63f689d43
container_end_page
container_issue
container_start_page 111180
container_title Brain research bulletin
container_volume 220
creator Liu, Kai-Li
Sun, Tian-Ze
Yang, Yu
Gao, Qian-Xi
Tu, Li-Mei
Yu, Jia-Yue
Tian, Qiao-Zhen
Fu, Li-Yan
Tang, Shu-Huan
Gao, Hong-Li
Qi, Jie
Kang, Yu-Ming
Yu, Xiao-Jing
description Neuromedin B (NMB) has potentially great impacts on the development of cardiovascular diseases by promoting hypertensive and sympatho-excitation effects. However, studies regarding the NMB function in paraventricular nucleus (PVN) are lacking. With selective neuromedin B receptor (NMBR) antagonist, BIM-23127, we aim to determine whether the blockade of NMB function in PVN could alleviate central inflammation and attenuate hypertensive responses. Spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were chronically infused with BIM-23127 in the PVN for 6 weeks. Mean arterial pressure (MAP) was assessed with tail cuff and electrophysiological acquisition systems. PVN tissues were collected to analyze expressions of Fra-LI, inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-10, and IL-4), renin-angiotensin system (angiotensin-converting enzyme (ACE), ACE2, and AT1-reporter (AT1-R)) and oxidative stress (reactive oxygen species (ROS), superoxide dismutase (SOD)1, NADPH oxidase (NOX)2, and NOX4). ELISA was used to detect inflammation indices, norepinephrine (NE), and nuclear factor κB (NF-κB) p65 in plasma and PVN tissue homogenate. Compared to WKY, SHR exhibited higher mean arterial pressure (MAP), plasma NE, and pro-inflammatory cytokines (PICs). Higher PVN levels of Fra-LI, PICs, ACE, AT1-R, ROS, NOX2, NOX4, and NF-κB p65, while lower central levels of anti-inflammatory cytokines (AICs), ACE2, and SOD1 were observed in SHR. Administration of BIM-23127 in PVN reversed all these changes in SHR. In SHR, blockade of NMBR in the PVN inhibited sympatho-excitation and attenuated hypertensive response. The attenuation mechanism may involve reducing inflammation and the RAS/ROS/ NF-κB pathways in PVN. [Display omitted] •The effect of chronic infusion of neuromedin B receptor blocker in PVN on spontaneous hypertension is reported.•PVN blockade of neuromedin B receptor attenuates hypertension and sympathoexcitation.•PVN blockade of neuromedin B receptor alleviates PVN inflammation through RAS/ROS/NF-κB signaling pathways.
doi_str_mv 10.1016/j.brainresbull.2024.111180
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_proquest_miscellaneous_3148841483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0361923024003149</els_id><doaj_id>oai_doaj_org_article_80383d57ba8143a09b70ba6110fbfc6a</doaj_id><sourcerecordid>3148841483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2347-414ae930facaccc19b1edbfc2cfec046c8140cd6eb42ffd8f2f9a0fe63f689d43</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhiMEokvhFZDFiUt27TjrONy6hUKlqkUtcLUmzpj14o1T27toT7wXD8Ez4ZJScWQuI43--X-Pv6J4xeicUSYWm3kXwA4BY7dzbl7Rqp6zXJI-KmZMNrysmrp5XMwoF6xsK06PimcxbiilQi7F0-KItw0Ty7aZFT9Wzutv0CPxhnz8ckkG3AW_xd4OZEUCahyTDwScw72FhJHYwTjYbiFZP5A8I2mN5PrkZnF9dbO4PCt__VyREdL6OxyylsTRDwkG9LvoDmR9GDEkHKLdIwmQ4vPiiQEX8cV9Py4-n737dPqhvLh6f356clHqitdNWbMasOXUgAatNWs7hn1ndKUNaloLLVlNdS-wqytjemkq0wI1KLgRsu1rflycT769h40ag91COCgPVv0Z-PBVQUhWO1SScsn7ZdNBNuVA266hHQjGqMmJArLX68lrDP52hzGprY0anZvOVJzVUuYXS56lbyapDj7GgOYhmlF1B1Nt1L8w1R1MNcHMyy_vc3ZdJvKw-pdeFrydBJh_bm8xqKgtDjrTy-RSPs3-T85vIM-6eg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3148841483</pqid></control><display><type>article</type><title>Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats</title><source>ScienceDirect Journals</source><creator>Liu, Kai-Li ; Sun, Tian-Ze ; Yang, Yu ; Gao, Qian-Xi ; Tu, Li-Mei ; Yu, Jia-Yue ; Tian, Qiao-Zhen ; Fu, Li-Yan ; Tang, Shu-Huan ; Gao, Hong-Li ; Qi, Jie ; Kang, Yu-Ming ; Yu, Xiao-Jing</creator><creatorcontrib>Liu, Kai-Li ; Sun, Tian-Ze ; Yang, Yu ; Gao, Qian-Xi ; Tu, Li-Mei ; Yu, Jia-Yue ; Tian, Qiao-Zhen ; Fu, Li-Yan ; Tang, Shu-Huan ; Gao, Hong-Li ; Qi, Jie ; Kang, Yu-Ming ; Yu, Xiao-Jing</creatorcontrib><description>Neuromedin B (NMB) has potentially great impacts on the development of cardiovascular diseases by promoting hypertensive and sympatho-excitation effects. However, studies regarding the NMB function in paraventricular nucleus (PVN) are lacking. With selective neuromedin B receptor (NMBR) antagonist, BIM-23127, we aim to determine whether the blockade of NMB function in PVN could alleviate central inflammation and attenuate hypertensive responses. Spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were chronically infused with BIM-23127 in the PVN for 6 weeks. Mean arterial pressure (MAP) was assessed with tail cuff and electrophysiological acquisition systems. PVN tissues were collected to analyze expressions of Fra-LI, inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-10, and IL-4), renin-angiotensin system (angiotensin-converting enzyme (ACE), ACE2, and AT1-reporter (AT1-R)) and oxidative stress (reactive oxygen species (ROS), superoxide dismutase (SOD)1, NADPH oxidase (NOX)2, and NOX4). ELISA was used to detect inflammation indices, norepinephrine (NE), and nuclear factor κB (NF-κB) p65 in plasma and PVN tissue homogenate. Compared to WKY, SHR exhibited higher mean arterial pressure (MAP), plasma NE, and pro-inflammatory cytokines (PICs). Higher PVN levels of Fra-LI, PICs, ACE, AT1-R, ROS, NOX2, NOX4, and NF-κB p65, while lower central levels of anti-inflammatory cytokines (AICs), ACE2, and SOD1 were observed in SHR. Administration of BIM-23127 in PVN reversed all these changes in SHR. In SHR, blockade of NMBR in the PVN inhibited sympatho-excitation and attenuated hypertensive response. The attenuation mechanism may involve reducing inflammation and the RAS/ROS/ NF-κB pathways in PVN. [Display omitted] •The effect of chronic infusion of neuromedin B receptor blocker in PVN on spontaneous hypertension is reported.•PVN blockade of neuromedin B receptor attenuates hypertension and sympathoexcitation.•PVN blockade of neuromedin B receptor alleviates PVN inflammation through RAS/ROS/NF-κB signaling pathways.</description><identifier>ISSN: 0361-9230</identifier><identifier>ISSN: 1873-2747</identifier><identifier>EISSN: 1873-2747</identifier><identifier>DOI: 10.1016/j.brainresbull.2024.111180</identifier><identifier>PMID: 39716597</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Hypertension ; Inflammation ; Neuromedin B receptor ; PVN ; RAS/ROS/ NF-κB pathway</subject><ispartof>Brain research bulletin, 2025-01, Vol.220, p.111180, Article 111180</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2347-414ae930facaccc19b1edbfc2cfec046c8140cd6eb42ffd8f2f9a0fe63f689d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39716597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Kai-Li</creatorcontrib><creatorcontrib>Sun, Tian-Ze</creatorcontrib><creatorcontrib>Yang, Yu</creatorcontrib><creatorcontrib>Gao, Qian-Xi</creatorcontrib><creatorcontrib>Tu, Li-Mei</creatorcontrib><creatorcontrib>Yu, Jia-Yue</creatorcontrib><creatorcontrib>Tian, Qiao-Zhen</creatorcontrib><creatorcontrib>Fu, Li-Yan</creatorcontrib><creatorcontrib>Tang, Shu-Huan</creatorcontrib><creatorcontrib>Gao, Hong-Li</creatorcontrib><creatorcontrib>Qi, Jie</creatorcontrib><creatorcontrib>Kang, Yu-Ming</creatorcontrib><creatorcontrib>Yu, Xiao-Jing</creatorcontrib><title>Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats</title><title>Brain research bulletin</title><addtitle>Brain Res Bull</addtitle><description>Neuromedin B (NMB) has potentially great impacts on the development of cardiovascular diseases by promoting hypertensive and sympatho-excitation effects. However, studies regarding the NMB function in paraventricular nucleus (PVN) are lacking. With selective neuromedin B receptor (NMBR) antagonist, BIM-23127, we aim to determine whether the blockade of NMB function in PVN could alleviate central inflammation and attenuate hypertensive responses. Spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were chronically infused with BIM-23127 in the PVN for 6 weeks. Mean arterial pressure (MAP) was assessed with tail cuff and electrophysiological acquisition systems. PVN tissues were collected to analyze expressions of Fra-LI, inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-10, and IL-4), renin-angiotensin system (angiotensin-converting enzyme (ACE), ACE2, and AT1-reporter (AT1-R)) and oxidative stress (reactive oxygen species (ROS), superoxide dismutase (SOD)1, NADPH oxidase (NOX)2, and NOX4). ELISA was used to detect inflammation indices, norepinephrine (NE), and nuclear factor κB (NF-κB) p65 in plasma and PVN tissue homogenate. Compared to WKY, SHR exhibited higher mean arterial pressure (MAP), plasma NE, and pro-inflammatory cytokines (PICs). Higher PVN levels of Fra-LI, PICs, ACE, AT1-R, ROS, NOX2, NOX4, and NF-κB p65, while lower central levels of anti-inflammatory cytokines (AICs), ACE2, and SOD1 were observed in SHR. Administration of BIM-23127 in PVN reversed all these changes in SHR. In SHR, blockade of NMBR in the PVN inhibited sympatho-excitation and attenuated hypertensive response. The attenuation mechanism may involve reducing inflammation and the RAS/ROS/ NF-κB pathways in PVN. [Display omitted] •The effect of chronic infusion of neuromedin B receptor blocker in PVN on spontaneous hypertension is reported.•PVN blockade of neuromedin B receptor attenuates hypertension and sympathoexcitation.•PVN blockade of neuromedin B receptor alleviates PVN inflammation through RAS/ROS/NF-κB signaling pathways.</description><subject>Hypertension</subject><subject>Inflammation</subject><subject>Neuromedin B receptor</subject><subject>PVN</subject><subject>RAS/ROS/ NF-κB pathway</subject><issn>0361-9230</issn><issn>1873-2747</issn><issn>1873-2747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqNkcFu1DAQhiMEokvhFZDFiUt27TjrONy6hUKlqkUtcLUmzpj14o1T27toT7wXD8Ez4ZJScWQuI43--X-Pv6J4xeicUSYWm3kXwA4BY7dzbl7Rqp6zXJI-KmZMNrysmrp5XMwoF6xsK06PimcxbiilQi7F0-KItw0Ty7aZFT9Wzutv0CPxhnz8ckkG3AW_xd4OZEUCahyTDwScw72FhJHYwTjYbiFZP5A8I2mN5PrkZnF9dbO4PCt__VyREdL6OxyylsTRDwkG9LvoDmR9GDEkHKLdIwmQ4vPiiQEX8cV9Py4-n737dPqhvLh6f356clHqitdNWbMasOXUgAatNWs7hn1ndKUNaloLLVlNdS-wqytjemkq0wI1KLgRsu1rflycT769h40ag91COCgPVv0Z-PBVQUhWO1SScsn7ZdNBNuVA266hHQjGqMmJArLX68lrDP52hzGprY0anZvOVJzVUuYXS56lbyapDj7GgOYhmlF1B1Nt1L8w1R1MNcHMyy_vc3ZdJvKw-pdeFrydBJh_bm8xqKgtDjrTy-RSPs3-T85vIM-6eg</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Liu, Kai-Li</creator><creator>Sun, Tian-Ze</creator><creator>Yang, Yu</creator><creator>Gao, Qian-Xi</creator><creator>Tu, Li-Mei</creator><creator>Yu, Jia-Yue</creator><creator>Tian, Qiao-Zhen</creator><creator>Fu, Li-Yan</creator><creator>Tang, Shu-Huan</creator><creator>Gao, Hong-Li</creator><creator>Qi, Jie</creator><creator>Kang, Yu-Ming</creator><creator>Yu, Xiao-Jing</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>202501</creationdate><title>Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats</title><author>Liu, Kai-Li ; Sun, Tian-Ze ; Yang, Yu ; Gao, Qian-Xi ; Tu, Li-Mei ; Yu, Jia-Yue ; Tian, Qiao-Zhen ; Fu, Li-Yan ; Tang, Shu-Huan ; Gao, Hong-Li ; Qi, Jie ; Kang, Yu-Ming ; Yu, Xiao-Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2347-414ae930facaccc19b1edbfc2cfec046c8140cd6eb42ffd8f2f9a0fe63f689d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Hypertension</topic><topic>Inflammation</topic><topic>Neuromedin B receptor</topic><topic>PVN</topic><topic>RAS/ROS/ NF-κB pathway</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Kai-Li</creatorcontrib><creatorcontrib>Sun, Tian-Ze</creatorcontrib><creatorcontrib>Yang, Yu</creatorcontrib><creatorcontrib>Gao, Qian-Xi</creatorcontrib><creatorcontrib>Tu, Li-Mei</creatorcontrib><creatorcontrib>Yu, Jia-Yue</creatorcontrib><creatorcontrib>Tian, Qiao-Zhen</creatorcontrib><creatorcontrib>Fu, Li-Yan</creatorcontrib><creatorcontrib>Tang, Shu-Huan</creatorcontrib><creatorcontrib>Gao, Hong-Li</creatorcontrib><creatorcontrib>Qi, Jie</creatorcontrib><creatorcontrib>Kang, Yu-Ming</creatorcontrib><creatorcontrib>Yu, Xiao-Jing</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Brain research bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Kai-Li</au><au>Sun, Tian-Ze</au><au>Yang, Yu</au><au>Gao, Qian-Xi</au><au>Tu, Li-Mei</au><au>Yu, Jia-Yue</au><au>Tian, Qiao-Zhen</au><au>Fu, Li-Yan</au><au>Tang, Shu-Huan</au><au>Gao, Hong-Li</au><au>Qi, Jie</au><au>Kang, Yu-Ming</au><au>Yu, Xiao-Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats</atitle><jtitle>Brain research bulletin</jtitle><addtitle>Brain Res Bull</addtitle><date>2025-01</date><risdate>2025</risdate><volume>220</volume><spage>111180</spage><pages>111180-</pages><artnum>111180</artnum><issn>0361-9230</issn><issn>1873-2747</issn><eissn>1873-2747</eissn><abstract>Neuromedin B (NMB) has potentially great impacts on the development of cardiovascular diseases by promoting hypertensive and sympatho-excitation effects. However, studies regarding the NMB function in paraventricular nucleus (PVN) are lacking. With selective neuromedin B receptor (NMBR) antagonist, BIM-23127, we aim to determine whether the blockade of NMB function in PVN could alleviate central inflammation and attenuate hypertensive responses. Spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were chronically infused with BIM-23127 in the PVN for 6 weeks. Mean arterial pressure (MAP) was assessed with tail cuff and electrophysiological acquisition systems. PVN tissues were collected to analyze expressions of Fra-LI, inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-10, and IL-4), renin-angiotensin system (angiotensin-converting enzyme (ACE), ACE2, and AT1-reporter (AT1-R)) and oxidative stress (reactive oxygen species (ROS), superoxide dismutase (SOD)1, NADPH oxidase (NOX)2, and NOX4). ELISA was used to detect inflammation indices, norepinephrine (NE), and nuclear factor κB (NF-κB) p65 in plasma and PVN tissue homogenate. Compared to WKY, SHR exhibited higher mean arterial pressure (MAP), plasma NE, and pro-inflammatory cytokines (PICs). Higher PVN levels of Fra-LI, PICs, ACE, AT1-R, ROS, NOX2, NOX4, and NF-κB p65, while lower central levels of anti-inflammatory cytokines (AICs), ACE2, and SOD1 were observed in SHR. Administration of BIM-23127 in PVN reversed all these changes in SHR. In SHR, blockade of NMBR in the PVN inhibited sympatho-excitation and attenuated hypertensive response. The attenuation mechanism may involve reducing inflammation and the RAS/ROS/ NF-κB pathways in PVN. [Display omitted] •The effect of chronic infusion of neuromedin B receptor blocker in PVN on spontaneous hypertension is reported.•PVN blockade of neuromedin B receptor attenuates hypertension and sympathoexcitation.•PVN blockade of neuromedin B receptor alleviates PVN inflammation through RAS/ROS/NF-κB signaling pathways.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39716597</pmid><doi>10.1016/j.brainresbull.2024.111180</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-9230
ispartof Brain research bulletin, 2025-01, Vol.220, p.111180, Article 111180
issn 0361-9230
1873-2747
1873-2747
language eng
recordid cdi_proquest_miscellaneous_3148841483
source ScienceDirect Journals
subjects Hypertension
Inflammation
Neuromedin B receptor
PVN
RAS/ROS/ NF-κB pathway
title Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A23%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blockade%20of%20PVN%20neuromedin%20B%20receptor%20alleviates%20inflammation%20via%20the%20RAS/ROS/NF-%CE%BAB%20pathway%20in%20spontaneously%20hypertensive%20rats&rft.jtitle=Brain%20research%20bulletin&rft.au=Liu,%20Kai-Li&rft.date=2025-01&rft.volume=220&rft.spage=111180&rft.pages=111180-&rft.artnum=111180&rft.issn=0361-9230&rft.eissn=1873-2747&rft_id=info:doi/10.1016/j.brainresbull.2024.111180&rft_dat=%3Cproquest_doaj_%3E3148841483%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2347-414ae930facaccc19b1edbfc2cfec046c8140cd6eb42ffd8f2f9a0fe63f689d43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3148841483&rft_id=info:pmid/39716597&rfr_iscdi=true